Monitoring of up to 15 years effects of lipoprotein apheresis on lipids, biomarkers of inflammation, and soluble endoglin in familial hypercholesterolemia patients

Abstract Background Lipoprotein apheresis (LA) is considered as an add-on therapy for patients with familial hypercholesterolemia (FH). We aimed to analyze the data collected in the last 15 years from FH patients treated with LA, to elucidate the benefit of this procedure with respect to plasma lipi...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	J. Víšek, M. Bláha, V. Bláha, M. Lášticová, M. Lánska, C. Andrýs, J. Duintjer Tebbens, Ivone Cristina Igreja e Sá, K. Tripská, M. Vicen, I. Najmanová, P. Nachtigal
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	BMC 2021-02-01
Cyfres:	Orphanet Journal of Rare Diseases
Pynciau:	Lipoprotein apheresis Familial hypercholesterolemia Lipids Inflammation Soluble endoglin
Mynediad Ar-lein:	https://doi.org/10.1186/s13023-021-01749-w
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!